Contrast-enhanced ultrasound (CEUS) liver imaging reporting and data system (LI-RADS) 2017 – a review of important differences compared to the CT/MRI system.
- Author:
Tae Kyoung KIM
1
;
Seung Yeon NOH
;
Stephanie R WILSON
;
Yuko KONO
;
Fabio PISCAGLIA
;
Hyun Jung JANG
;
Andrej LYSHCHIK
;
Christoph F DIETRICH
;
Juergen K WILLMANN
;
Alexander VEZERIDIS
;
Claude B SIRLIN
Author Information
- Publication Type:Review
- Keywords: Carcinoma, Hepatocellular; Liver; Ultrasonography; Contrast Media; Diagnosis, Ultrasonic
- MeSH: Carcinoma, Hepatocellular; Contrast Media; Data Collection; Diagnosis; Diagnostic Imaging; Humans; Information Systems*; Liver*; Magnetic Resonance Imaging; Ultrasonography*
- From:Clinical and Molecular Hepatology 2017;23(4):280-289
- CountryRepublic of Korea
- Language:English
- Abstract: Medical imaging plays an important role in the diagnosis and management of hepatocellular carcinoma (HCC). The Liver Imaging Reporting and Data System (LI-RADS) was initially created to standardize the reporting and data collection of CT and MR imaging for patients at risk for HCC. As contrast-enhanced ultrasound (CEUS) has been widely used in clinical practice, it has recently been added to the LI-RADS. While CEUS LI-RADS shares fundamental concepts with CT/MRI LI-RADS, there are key differences between the modalities reflecting dissimilarities in the underlying methods of image acquisition and types of contrast material. This review introduces a recent update of CEUS LI-RADS and explains the key differences from CT/MRI LI-RADS.
